Evidence map›Paper›PMID 35216031›Full record

ReviewViruses2022

Viral Aggregation: The Knowns and Unknowns.

Swechchha Pradhan, Arvind Varsani, Chloe Leff, Carter J Swanson, Rizal F Hariadi

Open access · goldAbstract readReview
In one paragraph

Review in Viruses, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Pathogenicity of a novel orthonairovirus, Iwanai Valley virus, in mice.The Journal of veterinary medical science · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Influence of operating state of a pilot-scale ultrafiltration system on virus removal for potable water reuse.Water science and technology : a journal of the International Association on Water Pollution Research · 2025
    Article
  9. Article
  10. Article
  11. Virion aggregation shapes infection dynamics and evolutionary potential.bioRxiv : the preprint server for biology · 2025
    Article
  12. Nonlytic Egress and Transmission in the Virus World.Annual review of biochemistry · 2025
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Swechchha PradhanCenter for Molecular Design and Biomimetics, The Biodesign Institute, Arizona State University, Tempe, AZ 85287, USA.ORCID 0000-0001-7550-5108
Arvind VarsaniThe Biodesign Center for Fundamental and Applied Microbiomics, Center for Evolution and Medicine, School of Life Sciences, Arizona State University, Tempe, AZ 85287, USA.ORCID 0000-0003-4111-2415
Chloe LeffSchool of Molecular Sciences, Arizona State University, Tempe, AZ 85287, USA.ORCID 0000-0002-9036-4099
Carter J SwansonCenter for Molecular Design and Biomimetics, The Biodesign Institute, Arizona State University, Tempe, AZ 85287, USA.ORCID 0000-0001-6697-9475
Rizal F HariadiCenter for Molecular Design and Biomimetics, The Biodesign Institute, Arizona State University, Tempe, AZ 85287, USA.ORCID 0000-0001-7840-859X
Arizona State University · USUniversity of Cape Town · ZA

Funding

Nanoscale reconstruction of mechanical systems involved in disease pathogenesisDP2AI144247 · NIAID · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI HARIADI, RIZAL FAJAR · 2018 to 2018
$2.4M
NIAID NIH HHS DP2 AI144247
6 · The paper itself

Abstract

Viral aggregation is a complex and pervasive phenomenon affecting many viral families. An increasing number of studies have indicated that it can modulate critical parameters surrounding viral infections, and yet its role in viral infectivity, pathogenesis, and evolution is just beginning to be appreciated. Aggregation likely promotes viral infection by increasing the cellular multiplicity of infection (MOI), which can help overcome stochastic failures of viral infection and genetic defects and subsequently modulate their fitness, virulence, and host responses. Conversely, aggregation can limit the dispersal of viral particles and hinder the early stages of establishing a successful infection. The cost-benefit of viral aggregation seems to vary not only depending on the viral species and aggregating factors but also on the spatiotemporal context of the viral life cycle. Here, we review the

Indexed as

VirionVirus ReplicationAnimalsBiological EvolutionHumansVirus Diseasesmultiplicity of infectionviral aggregationviral infectivityviral transmission

Identifiers

PMID35216031
PMCPMC8879382
OpenAlexW4213378449

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.